Abstract
Executive Summary
There are today more than 200 anti-angiogenic/vascular disruptive/vascular
targeting agents drugs in oncology, from early preclinical to marketed drugs.
Angiogenesis in Oncology: Drug Pipeline Update lists all drugs and gives you a
progress analysis on each one of them. Identified drugs are linked to 138
different targets. These targets are further categorized on the CD-ROM by 38
classifications of molecular function and with pathway referals to BioCarta,
KEGG and NetPath. Read more below on how the Angiogenesis in Oncology: Drug
Pipeline Update is organized.
How May Drug Pipeline Update Be of Use?
- Show investors/board/management that you are right on top of drug
development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc.
- Jump start competitive drug intelligence operations
- Excellent starting point for world wide benchmarking
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/out licensing strategy work
- Fast and easy way of tracking drugs using search engines; just one click
from inside the application and you may search the World Wide Web and PubMed
for any drug.
View Cart
